Read + Share
Amedeo Smart
Independent Medical Education
Weidinger S, Bewley A, Hong HC, Silvestre JF, et al. Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis. Br J Dermatol 2024 Dec 5:ljae439. doi: 10.1093.PMID: 39657020
Email
LinkedIn
Privacy Policy